Multifactorial intervention delays ESRD in diabetic nephropathy

07/18/2013 | Renal and Urology News

An analysis of data on 120 low-income patients with advanced diabetic nephropathy and chronic kidney disease showed that 13% of those assigned to multifactorial intervention developed end-stage renal disease at two years, compared with 28% of those who received usual care. More patients in the intervention group also attained an HbA1C of less than 7% and showed greater declines in albumin:creatinine ratio and better lipid/blood pressure control than those in the control group, researchers reported at the American Diabetes Association 73rd Scientific Sessions.

View Full Article in:

Renal and Urology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY